TAVI and coronary interventions: indications, technical considerations, and clinical scenarios: State-of-the-Art

In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Catalin Toma dive into the findings of SPIRARE II. Dr Toma shares the strategy behind enriching the trial's design; core efficacy and safety endpoint results (RV/LV ratio & MAE rates); the mechanics and potential advantages of the Vertex technology; and future clinical horizons for mechanical thrombectomy. Hosted on Acast. See acast.com/privacy for more information.

In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Philip Urban discuss the findings of SELUTION DeNovo HBR, comparing SEB versus DES PCI strategies. Dr Urban describes the dual-risk profile of the enrolled HBR patients and shares the hypothesis-generating results including 1-year TVF, BARC 3+ bleeding, and NACE rates which favoured the balloon arm – possibly linked to lower use of antiplatelet therapy in SEB-treated patients. Hosted on Acast. See acast.com/privacy for more information.

In this episode of Editor’s Choice, Dr Aaysha Cader and Dr Nilesh Pareek discuss the SCAI-V classification for cardiogenic shock in OHCA patients. Dr Pareek explains how both haemodynamic status and lactate thresholds are incorporated into a 2x2 factorial design, describes the surprising finding of higher mortality in the systemic ischaemia group versus the haemodynamic shock group, and compares this classification with predecessors SCAI 2019 and SCAI 2022. Hosted on Acast. See acast.com/privacy for more information.

In this episode of Editor’s Choice, Dr Aaysha Cader and Professor Gregory Lip compare the post-LAAO clinical outcomes of low-dose DOAC, DAPT, and SAPT, based on data from the TriNetX Global Network. With limited guideline recommendations currently in place, Professor Lip summarises the findings of the comparisons; he explains why, mechanistically, reduced-dose DOAC might be preferable to antiplatelet therapy after LAAO; and shares with Dr Cader some alternative medical therapies to LAAO, which may suit certain patients better. Hosted on Acast. See acast.com/privacy for more information.

In this episode of Editor's Choice, Dr Aaysha Cader speaks with Professor Niels van Royen and Doctor Rick Volleberg about the findings of the PECTUS-obs study. They discuss the association between high-risk plaque and an approximately twofold increase in 5-year MACE; plaque rupture as a marker of both local and systemic vulnerability; and why combining imaging and physiology may be key to managing non-culprit lesions. Hosted on Acast. See acast.com/privacy for more information.